Infectious Disease Control
Rockefeller virologist Charles M. Rice honored with Nobel Prize for research that contributed to a cure for hepatitis C
NEW YORK, Oct. 6, 2020 /PRNewswire/ -- Charles M. Rice, who studies disease-causing viruses and how the immune system defends against them, is this year's recipient of the Nobel Prize in Physiology or Medicine, the Nobel Foundation inStockholm, Sweden, announced today. Rice is the Maurice R. and ...
2020-10-06 03:20
3683
Smartphone-based Solutions Boost the Global Infectious Disease Point-of-Care Testing Market at an Explosive CAGR of 70.2% in 2020
Digital POCT platforms will enable diagnostic testing beyond the clinic, transforming how assay results are gathered and analyzed, finds Frost & Sullivan SANTA CLARA, California, Oct. 2, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Smartphone-based Solutions Spur the Global Infectious ...
2020-10-02 03:43
3868
GVN's Top Virus Experts Meet Together To Identify Most Promising Advances To Battle COVID-19 & Strategies To Prepare For Future Pandemics
BALTIMORE, Oct. 1, 2020 /PRNewswire/ -- The Global Virus Network (GVN), a coalition of the world's leading medical and basic virology research centers working to prevent illness and death from viral disease, convened a press conference with attendees from across the globe to discuss key takeaways...
2020-10-01 04:56
5501
Statement from Bill & Melinda Gates Foundation CEO Mark Suzman on Momentum in Global COVID-19 Response
SEATTLE, Sept. 30, 2020 /PRNewswire/ -- The death toll from COVID-19 passed one million this week. It is a sobering moment. But there is cause for optimism as recent days have seen a significant surge in momentum around global cooperation, which is our greatest strength when it comes to consignin...
2020-09-30 12:01
2369
BioGX launches CE-IVD Marked COVID-19, Influenza A/B, RSV Combo RT-PCR Test for the BD MAX™ System
AMSTERDAM, Sept. 30, 2020 /PRNewswire/ -- BioGX BV, the European subsidiary of Birmingham, Alabama based BioGX, announced availability of a CE-IVD marked test for simultaneous detection of SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus RNA in a patient sample using the BD MA...
2020-09-30 06:06
2737
The Copperline Mask: The First Face Mask in Asia Independently Verified to Kill SARS-CoV-2
SINGAPORE, Sept. 30, 2020 /PRNewswire/ -- Today, Yappie Pte. Ltd. ("Yappie") announced that Korea's Copperline Mask has been independently verified to be the first face mask inAsia to kill SARS-CoV-2. The Copperline Mask's patented ionised copper yarn knitted fabric actively eliminates bacteria ...
2020-09-30 03:56
3734
World Heart Federation says perfect storm for heart disease created by COVID-19
GENEVA, Sept. 28, 2020 /PRNewswire/ -- COVID-19 is creating a perfect storm for heart health, the World Heart Federation (WHF) warns on World Heart Day. Three main factors are contributing to this. First, people with COVID-19 and heart disease are among those with the highest risk of death and se...
2020-09-28 19:05
3302
Mumbai Municipal Commissioner I.S. Chahal Honoured With Global 'Covid Crusader Award-2020'
PUNE, India, Sept. 28, 2020 /PRNewswire/ -- Iqbal Singh Chahal, I.A.S., Municipal Commissioner of the Municipal Corporation ofGreater Mumbai, has become the first Indian bureaucrat to be recognised and receive global acknowledgment for his contribution in controlling the novel coronavirus infect...
2020-09-28 18:08
3335
Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study
* New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced * Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose and throat, in a gold-standar...
2020-09-28 06:00
2585
New Development Bank prices USD 2 billion benchmark bond to further support COVID emergency response
* The New Development Bank's (NDB) latest issue in the international capital markets represents another strong step forward in developing its yield curve. * The USD-denominated 5-year COVID Response Bond is yet another demonstration of NDB's commitment to fighting the coronavirus outbreak in i...
2020-09-24 12:55
3566
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
NEW BRUNSWICK, New Jersey, Sept. 23, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical ...
2020-09-23 19:25
5263
Biorasi Commended by Frost & Sullivan for its Full-service Offering to Drive Rare Disease Patient Recruitment for CROs
SANTA CLARA, California, Sept. 22, 2020 /PRNewswire/ -- Based on its recent analysis of the North American contract research organization (CRO) market, Frost & Sullivan recognizesBiorasi, LLC with the 2020 North American Entrepreneurial Company of the Year Award. Biorasi's milestone-based, patie...
2020-09-22 21:00
2201
Qatar Foundation's WISE Announces Special E-Book
Education Disrupted, Education Reimagined - Responses from education's frontline during the COVID-19 pandemic and beyond DOHA, Qatar, Sept. 22, 2020 /PRNewswire/ -- WISE, a Qatar Foundation global education think-tank, in partnership with Salzburg Global Seminar, and Diplomatic Courier, is pleas...
2020-09-22 06:14
4005
Asia-Pacific's 5G Digital Factory Revenue Primed for a Post-COVID-19 Recovery Worth US$60 Billion in 2030
SINGAPORE, Sept. 17, 2020 /PRNewswire/ -- COVID-19 initially slowed mobile phone sales in theAsia Pacific and disrupted supply chains and demand for certain 5G-related end verticals. However, it also caused an increase in broadband traffic and 5G use cases such asSouth Korea using 5G to livestrea...
2020-09-17 20:30
4219
Acellular-Convalescent Plasma (A-CP) and New Technologies Introduced by Regen Lab®
LAUSANNE, Switzerland, Sept. 17, 2020 /PRNewswire/ -- Convalescent Plasma (CP), also calledPassive Antibody Therapy, for the treatment of COVID-19 infected patients was approved by the US-FDA two weeks ago. This great news was based on a nationwide evaluation in 14 U.S. medical institutions, and...
2020-09-17 04:00
2369
Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond
NEW YORK, Sept. 16, 2020 /PRNewswire/ -- Today, Havas Health & You (HH&Y) announces the details of long-term global research project,Behind the Mask, a longitudinal, multi-armed study which focuses on documenting the ongoing evolution of health and wellness. This sector has seen dynamic shifts in...
2020-09-16 21:15
2406
eGeneration Partners with Bangladesh Government to Fight Pandemic with Technology
DHAKA, Bangladesh, Sept. 16, 2020 /PRNewswire/ -- The COVID-19 pandemic has shaken the whole world andBangladesh is no difference. The country has observed the longest general holidays and taken social distancing measures to keep contamination in check. eGeneration, one of the leading IT companie...
2020-09-16 13:54
2177
Devan Lauded by Frost & Sullivan for its Antimicrobial Technology with Unique Quaternized Silane Chemistry
The non-leaching attributes of the technology coupled with its ability to reduce microbial mutation make it a potential candidate for textiles where durability and safe human contact are highly valued LONDON, Sept. 16, 2020 /PRNewswire/ -- Based on its recent analysis of the European antimicro...
2020-09-16 03:39
2555
Gates Foundation's Annual Goalkeepers Report Shows COVID-19 Has Stalled 20 Years of Progress, Calls for Global Response to End the Pandemic
Report shows how economic damage has reinforced inequities and derailed achievement of the UN Sustainable Development Goals; spotlights countries innovating to meet challenges SEATTLE, Sept. 15, 2020 /PRNewswire/ -- The Bill & Melinda Gates Foundation today launched its fourth annual Goalkeepers...
2020-09-15 11:00
2771
Global Fund Partnership Has Saved 38 Million Lives - but COVID-19 Could Wipe Out Progress
GENEVA, Sept. 14, 2020 /PRNewswire/ -- A new report by the Global Fund to Fight AIDS, Tuberculosis and Malaria is a call to action to urgently invest to protect decades of progress against HIV, TB and malaria that are being derailed as a knock-on effect of the COVID-19 pandemic. According to ...
2020-09-14 10:39
3734
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5214
